🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550
This study is an open-label, multicenter Phase IB/II clinical trial to eval...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2024-07-02
Trial ID
NCT06474455
This study is an open-label, multicenter Phase IB/II clinical trial to eval...
Status
Unknown
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT06092268
HS-20117 is a fully-human EGFR-MET immunoglobulin G1(IgG1)-like bispecific ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2024-05-28
Trial ID
NCT06417008
Treatments Being Tested
This is a Phase Ib study to evaluate the safety, tolerability, and efficacy...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-09
Trial ID
NCT06585059
Treatments Being Tested
This study is a prospective, multicenter, single arm clinical study. Thirty...
Status
Recruiting
Location
First Affiliated Hospital of Kunming University
Start Date
2023-10-30
Trial ID
NCT06102928
Treatments Being Tested
Most of the lung cancer patients treated in hospitals in China are in advan...
Status
Unknown
Location
Zhou Chengzhi
Start Date
2022-01-01
Trial ID
NCT05826483
Treatments Being Tested